Skip to main content

Concierge cardiology · UK

TAVI - a new aortic valve, no sternotomy.

Transcatheter aortic valve implantation for severe symptomatic aortic stenosis - a new valve delivered through the groin, no open-heart surgery. Consultant interventional cardiologist, heart-team MDT and CT sizing before the valve is chosen.

See indicative pricing
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why patients choose us

  • 01

    A consultant interventional cardiologist plus surgical MDT

    A named interventional cardiologist with high TAVI volume, backed by a cardiothoracic surgeon and heart-team MDT - not a single-operator decision.

  • 02

    CT sizing before valve choice, not after

    ECG-gated CT-angiography to size the annulus, root and access route - and to choose the right valve type (balloon-expandable or self-expanding) for your anatomy.

  • 03

    Independent, and free

    We are paid by no clinic or manufacturer, so whether TAVI, surgical AVR or medical management fits you best is impartial and costs you nothing.

Indicative pricing

What a private TAVI costs in the UK.

Indicative ranges across our partner cardiac centres. Send the details and we quote firm figures across two or three options, with insurer cover checked.

In short

Standard transfemoral TAVI in our network: £35,000–£55,000, home in 2–3 nights.

Item Indicative range
Interventional cardiology consultation £300–£500
Full workup (echo, CT, angio, bloods) £2,500–£4,500
TAVI - transfemoral, balloon-expandable £35,000–£55,000
TAVI - transfemoral, self-expanding £38,000–£58,000
TAVI - complex anatomy or alternative access £50,000–£65,000
Valve-in-valve TAVI (failed prior valve) £40,000–£60,000
Post-TAVI cardiac rehab (per week) £1,500–£3,500

Prices vary by hospital, by the operator, by valve platform and by whether an alternative access route is needed. Cardiac rehab and any post-procedure pacemaker are additional. NHS TAVI is available through cardiology heart-team MDTs at approved centres. We come back with a firm quote within one working day.

The problem

The right patient, the right valve, and a real heart-team decision.

TAVI is where private cardiology sometimes drifts - a single-operator decision, valve choice made on brand loyalty and surgical AVR ruled out on paper. We fix all three before you consent.

  • A real heart-team decision

    Interventional cardiologist, cardiothoracic surgeon, imaging and geriatrics in the room - not a single opinion.

  • Match the valve to your anatomy

    Balloon-expandable and self-expanding valves have different strengths. CT-angiography drives the choice, not marketing.

  • Surgical AVR still deserves the conversation

    For some patients - younger, bicuspid, complex - surgical AVR is still the better long-term answer. We say so if it applies.

The journey

From enquiry to recovery - what happens, in order.

One heart team from first message through workup, MDT, TAVI and long-term follow-up.

  1. 01

    Before

    You tell us what is going on

    A short, confidential form. Symptoms, echo results, other heart disease, prior heart surgery, frailty and comorbidities.

  2. 02

    Before

    We come back with a recommendation

    Within one working day: whether TAVI, surgical AVR or medical management fits best, and an indicative price. STS and EuroSCORE risk calculated.

  3. 03

    Before

    Full workup and CT-angiography

    Transthoracic echo, ECG-gated CT-angiography of the aortic root and access vessels, coronary angiogram, bloods, frailty score and dental review.

  4. 04

    Before

    Heart-team MDT

    Discussion at the heart-team MDT - interventional cardiologist, cardiothoracic surgeon, cardiac imaging and geriatrician. Valve type and access route agreed. Surgical AVR ruled in or out.

  5. 05

    On the day

    Admission and procedure

    Same-day admission. Transfemoral (usual route) under conscious sedation or GA. Balloon-expandable or self-expanding valve deployed. 60–120 minutes on the table.

  6. 06

    On the day

    Recovery and discharge

    CCU or step-down overnight. Temporary pacing wire monitored for conduction issues. Discharge usually at 2–3 days.

  7. 07

    After

    Review, echo and long-term follow-up

    Echo at 4–6 weeks. Cardiology review at 3 months. Annual echo and cardiology follow-up thereafter, endocarditis prevention.

Typical end-to-end: 2–4 weeks from enquiry to TAVI. Full recovery: 4–6 weeks.

When it helps

When TAVI is the right step.

The clinical pictures we see most, plus the one red flag that means same-day cardiology rather than a routine workup.

  • Severe symptomatic aortic stenosis

    Peak velocity above 4 m/s, mean gradient over 40 mmHg or aortic valve area below 1.0 cm2 with breathlessness, syncope, angina or heart failure.

  • High or intermediate surgical risk

    STS score above 4 percent, older age, frailty, prior cardiac surgery or major comorbidities - TAVI is preferred over surgical AVR here.

  • Low-risk patients (age-selected)

    Landmark trials support TAVI in selected lower-risk patients too - anatomy and life expectancy drive the choice more than age alone.

  • Failed bioprosthetic surgical valve

    A degenerated surgically implanted tissue valve - valve-in-valve TAVI avoids repeat sternotomy in most cases.

  • Bicuspid aortic valve

    A congenital two-cusp valve - TAVI is feasible in selected anatomy with careful CT planning and self-expanding platforms.

  • Severe aortic regurgitation (selected)

    Off-label but growing - specific TAVI platforms are being used for pure aortic regurgitation in patients unsuitable for surgery.

  • Post-radiation or porcelain aorta

    A heavily calcified ascending aorta or prior mediastinal radiation makes surgical AVR dangerous - TAVI is often the only realistic option.

  • Red flag: decompensated heart failure or syncope

    Acute pulmonary oedema, recurrent syncope or a life-threatening arrhythmia needs same-day cardiology - not a routine TAVI workup timeline.

Valve and access options

Platform and access route both matter - here is the map.

What each option involves - balloon-expandable and self-expanding valves, transfemoral versus alternative access, valve-in-valve and cerebral protection.

  • Balloon-expandable valve (Edwards SAPIEN)

    A cobalt-chromium frame with bovine pericardial leaflets, deployed by balloon inflation. Precise placement, low pacemaker rate. The commonest platform worldwide.

  • Self-expanding valve (Medtronic Evolut)

    A nitinol frame with porcine pericardial leaflets, deployed by sheath withdrawal. Excellent for small annuli and bicuspid anatomy; slightly higher pacemaker rate.

  • Mechanically expandable (Boston Lotus, discontinued)

    Now withdrawn from most markets - mentioned for historical reference and for patients with a prior Lotus valve now needing valve-in-valve.

  • Transfemoral access

    The default route - a catheter through the femoral artery under local anaesthetic and sedation. Discharge in 2–3 nights.

  • Transapical or subclavian access

    Alternative access when femoral vessels are unsuitable. Requires small chest or clavicular incision under GA. Longer stay.

  • Valve-in-valve TAVI

    A new TAVI valve placed inside a failed surgical bioprosthesis. Avoids repeat sternotomy in most cases; careful sizing to avoid coronary obstruction.

  • Cerebral embolic protection

    A filter device that catches debris during valve deployment and reduces stroke risk. Used routinely by many operators in higher-risk anatomy.

  • Concomitant PCI

    Where significant coronary disease coexists, staged or same-session percutaneous coronary intervention is arranged with the interventional team.

Our vetted UK network

A small panel of TAVI centres, we picked them.

High-volume interventional cardiology centres with on-site cardiothoracic surgery across London and the major UK cities. Introductions are made privately, once we understand your case.

Selection criteria

How we choose every TAVI centre in our network.

A UK hybrid cardiac catheter lab set up for TAVI
Heart-team led cardiology
  • Consultant interventional cardiologists with high TAVI volume and published outcomes

  • On-site cardiothoracic surgery, so a heart-team MDT decision is real, not paper

  • Full imaging suite: TOE, ECG-gated CT-angio and same-day coronary angiography

  • Cardiac rehabilitation and geriatrics input for older or frailer patients

Safety and recovery

What to expect afterwards - honestly.

TAVI is a mature procedure in expert hands. The things worth planning are pacemaker risk, vascular access, and long-term follow-up.

  • Sedation or GA, in a hybrid theatre

    Transfemoral TAVI is usually done under conscious sedation with local anaesthetic to the groin. GA is used for alternative access or complex anatomy.

  • Vascular access complications

    Bleeding, haematoma or vessel injury at the femoral artery in 3–6 percent. Percutaneous closure and imaging control keep serious complications uncommon.

  • New pacemaker in around 10–20 percent

    The conduction tissue lies just below the aortic valve. New atrioventricular block needing a permanent pacemaker is one of the main TAVI-specific issues.

  • Stroke, around 2–4 percent

    Stroke risk is reduced with cerebral embolic protection devices in high-risk anatomy. Same-day imaging and neurology cover are standard.

  • Paravalvular leak

    Small leaks around the new valve happen in a minority. Modern valves have skirts that markedly reduce this. Significant leak may need a balloon post-dilation or, rarely, a second valve.

  • Coronary obstruction

    A rare but serious complication where the displaced native valve or the TAVI frame covers a coronary ostium. Careful CT planning and, where needed, chimney stenting mitigate the risk.

  • Kidney injury and contrast load

    Contrast used for imaging and deployment can stress the kidneys. Hydration protocols and minimum-contrast techniques are standard.

  • Recovery and rehab

    Back to normal daily activity within 2–4 weeks. Cardiac rehab starts at 2–4 weeks. Long-term antiplatelet or oral anticoagulant regimen tailored to the patient.

  • Red flags after TAVI

    Sudden breathlessness, chest pain, one-sided weakness, black-out, groin swelling, fever, or a resting pulse below 40 need the same-day team or A&E, not a routine call.

Reading your procedure note

Your TAVI note in four parts. Read the last one first.

Whichever valve was used - balloon-expandable or self-expanding - the note the interventional cardiologist sends you keeps to the same shape.

A UK consultant interventional cardiologist reviewing TAVI imaging

A quiet reminder

Cardiology language is precise and can read coldly - we translate it for you.

If you would like us to talk you through the procedure note and the echo before your review, just ask.

  1. 01 Header

    Valve, access route and rationale

    Which valve platform was used, size, access route, and why this valve was chosen at MDT.

  2. 02 Technique

    Deployment and imaging

    Fluoroscopy time, contrast volume, cerebral protection, any pre- or post-dilation, and the final position on aortography.

  3. 03 Findings

    Function on discharge

    Post-procedure gradient, paravalvular leak grade, ECG changes and any new pacemaker.

  4. 04 Impression

    Medications and follow-up

    Read this first: antiplatelet or anticoagulant plan, echo timing, cardiology follow-up, endocarditis prevention and red flags.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

TAVI is usually covered where the patient meets clinical criteria and the case is discussed at a heart-team MDT. We confirm cover with the insurer before booking and pursue NHS access first where that fits better.

Frequently asked

Everything we get asked about TAVI.

Quick answers on candidacy, valve durability, recovery, risks and cost.

  • What is TAVI and how is it different from open surgery?

    TAVI (transcatheter aortic valve implantation) replaces a diseased aortic valve using a catheter usually threaded through a femoral artery in the groin, so there is no sternotomy, no bypass machine and no long incision. Surgical AVR opens the chest, stops the heart on a bypass machine and sews a new valve in. TAVI has a much shorter stay and recovery; surgical AVR still suits certain younger patients and complex anatomy.

  • Who is TAVI for?

    The main indication is severe symptomatic aortic stenosis. Older, frailer patients and those at intermediate or high surgical risk have been the classic candidates. Landmark trials now support TAVI in selected lower-risk patients too. Bicuspid anatomy, failed surgical bioprostheses (valve-in-valve) and porcelain aorta are also common indications.

  • How long does recovery take?

    Hospital stay is typically 2–3 nights after transfemoral TAVI, longer for alternative access. Most patients are back to light daily activity in 1–2 weeks, driving in 1–2 weeks (subject to any pacemaker rules), and full activity by 4–6 weeks. Cardiac rehab starts at 2–4 weeks.

  • What are the main risks?

    New pacemaker requirement in 10–20 percent, stroke in 2–4 percent, vascular access complications in 3–6 percent, and small paravalvular leaks in a minority. Serious complications are uncommon in high-volume centres. Age and frailty are the biggest drivers of overall risk.

  • How long does a TAVI valve last?

    Ten-year durability data now show that TAVI valves last comparably to surgical bioprosthetic valves in the medium term. Longer-term data (15–20 years) are still accruing. Valve-in-valve TAVI is a real option if a TAVI valve eventually degenerates.

  • Is TAVI available on the NHS?

    Yes. TAVI is well-established on the NHS through cardiology heart-team MDTs at approved centres for patients with severe symptomatic aortic stenosis meeting NICE criteria. Waits vary. Private TAVI removes the wait and offers choice of centre and consultant, and is often the route for very fit patients pushing for early treatment.

  • How much does private TAVI cost in the UK?

    Roughly £35,000–£55,000 for a standard transfemoral case, £38,000–£58,000 for self-expanding platforms, £50,000–£65,000 for complex or alternative-access cases, and £40,000–£60,000 for valve-in-valve. Full workup adds around £2,500–£4,500. Rehab is extra. We confirm a firm figure within one working day.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.

WhatsApp us Reply within 24h · Mon–Fri
Call